Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination.
about
Oligodendrogenesis in the normal and pathological central nervous systemRegenerative Capacity of Macrophages for RemyelinationAstrocytes in Oligodendrocyte Lineage Development and White Matter PathologyThe multifaceted role of astrocytes in regulating myelinationOligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and UpdateStructural and functional properties of platelet-derived growth factor and stem cell factor receptorsPromoting remyelination in multiple sclerosis-recent advancesSpatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair primingMechanisms of cell-cell interaction in oligodendrogenesis and remyelination after strokeMyelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signallingRole of platelet-derived growth factors in physiology and medicineAge-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiencyInefficient clearance of myelin debris by microglia impairs remyelinating processesEndogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain.Tapping into the glial reservoir: cells committed to remaining uncommitted.New developments in the treatment of optic neuritis.Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination.Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.The NG2 proteoglycan promotes oligodendrocyte progenitor proliferation and developmental myelinationBrain abnormalities and glioma-like lesions in mice overexpressing the long isoform of PDGF-A in astrocytic cells.Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination.Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelinationAge-related changes in human and non-human primate white matter: from myelination disturbances to cognitive decline.Zebrafish regenerate full thickness optic nerve myelin after demyelination, but this fails with increasing age.Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic.Targeting the PDGF signaling pathway in the treatment of non-malignant diseases.Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model.Deregulated proliferation and differentiation in brain tumors.Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination.Extracellular acidic pH inhibits oligodendrocyte precursor viability, migration, and differentiationEndogenous cell repair of chronic demyelination.Optimizing culture medium composition to improve oligodendrocyte progenitor cell yields in vitro from subventricular zone-derived neural progenitor cell neurospheres.Cell therapy for multiple sclerosis.Glia Disease and Repair-RemyelinationIdentification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.Demyelination as a rational therapeutic target for ischemic or traumatic brain injury.Evaluating Tissue-Specific Recombination in a Pdgfrα-CreERT2 Transgenic Mouse Line.Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors
P2860
Q21129352-E3C5A11B-FD2C-40AF-A20B-101017B5C122Q26744475-6D7A8ED5-697B-483B-B39A-E0CB334882FBQ26744749-2686D816-8D93-492A-8C02-233986BD6193Q26764727-48A0AB86-0E8C-4EF6-A302-C639F30E57CAQ26780518-E9BC459C-7F78-400B-8612-1CE7003F5D83Q26829546-4CF8B88C-BFBF-4886-92DA-804FBEAC7EF4Q27010398-52E84A77-514B-4B23-975A-C2771ECFE1E9Q27330010-91C73DC6-093C-4A32-A6EC-56276162D758Q28083718-48BDCF8E-29BB-480A-A2CC-C247ED457DC9Q28308310-D9B8745D-FA21-45A4-96EB-AC1F1238A89BQ29615222-B3DECF18-4E11-4B8A-AE42-B3F3066790C7Q30052479-9D398091-1C78-4B0B-AF85-8DE55151A6CBQ30636334-3E01C20F-E5FF-47BC-A34E-6CD22DC43C4AQ33618997-A33FE643-C86F-4593-A129-38552E580FABQ33631820-C8C65769-3162-4693-89BA-F9983190119AQ33643732-C11E6C69-BF47-4CDE-9E1F-4F2C22E9154DQ33702072-D3CC8D16-9244-4CFF-94C7-F3D5290B5CC8Q33735502-FDB8E648-5FE1-4ED9-8191-6A1A18ACE00FQ33740931-27669DD1-911C-4EC7-9C89-BF171BB9969CQ33761196-9E6D266A-498E-4A84-96C4-4449B3286145Q33872283-A157D828-8F0B-4673-AD43-E8BB538CC986Q33894302-02558FB4-6C7E-417E-85BC-EA5D8DC37C8FQ33917691-1FF8214D-752E-4230-9F89-50A83CFA7360Q34112815-CD74F9F7-AE31-4038-93C0-371E8778C4F7Q34184853-E84244A0-1E5A-4DCD-BCFF-41EABB7312F5Q34345195-F35803FD-87F4-47C2-817B-6E8360098FCDQ34352802-A1464193-2732-4DF8-9F12-F2D74AED468EQ34403740-28AD903F-42F7-4DF9-875A-608852E9D930Q34813347-DBB953B9-E0A0-4370-8F64-E4AEF8C0F6DDQ34859989-0FCF8889-5CB6-48B4-AD90-35F46A868FD8Q35009443-991F0511-5531-45E4-83E8-F9311008A5ABQ35010204-754B542A-E2D4-4873-A9A6-7B2A1A5591FDQ35129300-9D7EF9B6-3656-4AE6-8837-9BF38138A24DQ35594519-21D14F92-754A-479B-8DB0-3DDDC00E795FQ35648117-BF7CC7A2-470F-4985-BECD-E124F3A8B408Q35795587-C5BA59B1-47BC-4686-8E38-78919253357BQ36088126-595F826B-9883-49D1-A65B-66C80482517EQ36090107-BDE847B3-6ECB-45F1-80BB-536F23DA6C27Q36132458-74146234-8B37-4CDB-8F8D-6D3091B98CF7Q36145960-F2D34A90-8CEB-4A5A-84A5-8FBE5985D156
P2860
Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Platelet-derived growth factor ...... e following CNS demyelination.
@en
Platelet-derived growth factor ...... e following CNS demyelination.
@nl
type
label
Platelet-derived growth factor ...... e following CNS demyelination.
@en
Platelet-derived growth factor ...... e following CNS demyelination.
@nl
prefLabel
Platelet-derived growth factor ...... e following CNS demyelination.
@en
Platelet-derived growth factor ...... e following CNS demyelination.
@nl
P50
P1476
Platelet-derived growth factor ...... se following CNS demyelination
@en
P2093
Rachel H Woodruff
P304
P356
10.1016/J.MCN.2003.10.014
P577
2004-02-01T00:00:00Z